Clinical Trial Update: Tumor Markers in Lung Cancer

View source ↗

Summary

The document reports the completed clinical trial studying tumor markers in lung cancer. It lists the University of Oklahoma as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Oklahoma | Conditions: Lung Cancer | Status: COMPLETED